Patent details

EP2833864 Title: PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS

Basic Information

Publication number:
EP2833864
PCT Application Number:
EP2013056867
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137146189
PCT Publication Number:
WO2013149987
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS
French Title of Invention:
FORMULATIONS PHARMACEUTIQUES COMPRENANT DES ANTAGONISTES DE CCR3
German Title of Invention:
PHARMAZEUTISCHE FORMULIERUNGEN MIT CCR3-ANTAGONISTEN
SPC Number:

Dates

Filing date:
02/04/2013
Grant date:
19/12/2018
EP Publication Date:
11/02/2015
PCT Publication Date:
10/10/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/12/2018
EP B1 Publication Date:
19/12/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
02/04/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/12/2018
 
 

Name:
Alkahest, Inc.
Address:
125 Shoreway Road, Suite D, San Carlos, CA 94070, United States (US)

Agent

Name:
GRUND Intellectual Property Group
From:
25/02/2019
Address:
Steinsdorfstrasse 2, 80538, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
FETSCHER, Alfred
Address:
Germany (DE)

2

Name:
SCHER, Jochen Matthias
Address:
Germany (DE)

Priority

Priority Number:
12163078
Priority Date:
04/04/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/16; A61K 9/20; A61K 9/28; A61K 9/48; A61K 31/4545; A61P 29/00;

Publication

European Patent Bulletin

1

Issue number:
201851
Publication date:
19/12/2018
Description:
Grant (B1)

2

Issue number:
201904
Publication date:
23/01/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
17/04/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
PAVIS PAYMENTS GMBH
Filing date Document type Number of pages
25/02/2019 Power Of Attorney 4
11/03/2019 Outgoing Correspondence 1